SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US OTC > Biotechs > Amarantus Bioscience Holdings Inc. (AMBS)

Price target of AMBS at $1.25!! All aboard!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
barbershop Member Profile
Member Level 
Followed By 61
Posts 9,766
Boards Moderated 0
Alias Born 10/26/09
160x600 placeholder
Advertisement
Amarantus BioScience, U.S. Army and Rutgers University in Partnership to Expand Development of Engineered Skin Substitute (ES... "GlobeNewswire Inc." - 8/3/2015 6:00:00 AM
Amarantus Announces Publication of a Clinical Study of MSPrecise(R) Diagnostic for Identification of Relapsing-Remitting Mult... "GlobeNewswire Inc." - 7/29/2015 7:35:00 AM
AMARANTUS BIOSCIENCE - BUILDING UP THERAPEUTICS ASSETS "InvestorsHub NewsWire" - 7/28/2015 1:15:01 AM
Amarantus Diagnostics Establishes Strategic Advisory Committee "GlobeNewswire Inc." - 7/27/2015 7:35:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/22/2015 4:16:56 PM
Amarantus Diagnostics Meets Primary and Secondary Endpoints in Blinded, Multi-Center LP-002 Clinical Study for LymPro(R) Bloo... "GlobeNewswire Inc." - 7/22/2015 10:30:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 7/21/2015 5:02:26 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/20/2015 5:13:21 PM
Amarantus Announces First Patient Dosed in Eltoprazine Phase 2b Study for Treatment of Parkinson's Disease Levodopa-Induced D... "GlobeNewswire Inc." - 7/20/2015 7:05:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 7/16/2015 5:04:45 PM
Amarantus Completes Acquisition of ESS From Lonza for the Treatment of Severe Burns "GlobeNewswire Inc." - 7/15/2015 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/15/2015 7:01:49 AM
Amarantus to Commence Trading on the OTCQX Marketplace Under Existing Ticker Symbol AMBS "GlobeNewswire Inc." - 7/13/2015 7:05:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 7/13/2015 6:01:27 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/8/2015 5:05:22 PM
Amarantus Announces Issuance of United States Patent No. 9,066,903 Covering Proprietary Methods of Administration of Eltopraz... "GlobeNewswire Inc." - 6/30/2015 8:35:00 AM
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 6/23/2015 4:22:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/15/2015 4:06:38 PM
Amarantus Announces Presentation of Eltoprazine Phase 1/2a Clinical Data at the 19th International Congress of Parkinson's Di... "GlobeNewswire Inc." - 6/15/2015 7:05:00 AM
Amarantus to Present at the BIO International Convention "GlobeNewswire Inc." - 6/10/2015 8:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/9/2015 5:17:35 PM
Amarantus Completes Capital Restructuring in Preparation for National Exchange Listing "GlobeNewswire Inc." - 6/9/2015 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/9/2015 12:08:08 PM
Amarantus Diagnostics Announces Acceptance of Two Late-Breaking Abstracts on LymPro Test(R) Data at the 2015 Alzheimer's Asso... "GlobeNewswire Inc." - 6/9/2015 10:58:03 AM
barbershop Member Level  Wednesday, 12/26/12 08:08:01 AM
Re: fouraces post# 26607
Post # of 116681 
Price target of AMBS at $1.25!! All aboard!! Wow. Talk about a positive investor note. Abbot is a huge player. Monster.

By reading this or any of my posts, you are accepting the sole responsibility for your own investment decisions. Never buy any stock based on what is posted above. Due your own DD.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist